Status:
COMPLETED
Early Palliative Care for Patients With Severe and Very Severe COPD: a Randomised Study
Lead Sponsor:
University Hospital, Geneva
Collaborating Sponsors:
Swiss National Science Foundation
Conditions:
COPD
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common and, despite existing treatment options, progressive lung disease. Patients with COPD often have only limited access to palliative care. The go...
Detailed Description
The primary objective of the study is to assess the effectiveness of the introduction of early specialized palliative care on hospital, intensive care unit and emergency admissions of patients with se...
Eligibility Criteria
Inclusion
- COPD defined according to GOLD criteria (FEV1/FVC \< 70%) stage III or IV (FEV1 \< 50% predicted)
- and/or long term treatment with either domiciliary oxygen or home mechanical ventilation
- and or one or more hospital admissions in the previous year for an acute exacerbation
Exclusion
- Moderate or severe cognitive impairment (MMSE\<20)
Key Trial Info
Start Date :
September 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2017
Estimated Enrollment :
51 Patients enrolled
Trial Details
Trial ID
NCT02223780
Start Date
September 1 2013
End Date
July 1 2017
Last Update
November 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Geneva
Geneva, Switzerland